News | Proton Therapy | August 30, 2021

IBA leverages its expert community of users to improve proton therapy and make it accessible to a larger range of patients


August 30, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions, is co-funding the ProtectTrial initiative with six European IBA Proteus centers, harnessing their expertise to provide high quality clinical data. The objective of the trial is to demonstrate the clinical benefits of proton therapy on esophageal cancer. This is yet another demonstration of IBA’s unrivaled dedication to proton therapy as a treatment modality. IBA has developed the largest and most knowledgeable community of users who have together treated well over 100,000 patients with proton therapy.

Together with its customers, as well as industry partners such as Elekta, RaySearch, Philips and many others, IBA is shaping the future of proton therapy by developing proton therapy systems and dosimetry solutions that will allow patients to be treated with increased accuracy. IBA’s comprehensive Motion Management package will help clinicians to treat more indications more confidently. Additionally, IBA’s unique DynamicARC technology has been developed to enable clinicians to deliver faster, simpler and sharper treatment.

Also, IBA is committed to bringing ConformalFLASH (Flash Therapy) into the clinic alongside its clinical partners, given its tremendous potential to radically change the radiation therapy landscape.

Olivier Legrain, Chief Executive Officer of IBA commented: "We are very happy to reconnect face to face with our customers at ESTRO’s annual congress and invite selected professionals to visit our center in Madrid. Our mission is to improve the clinical performance of our current and future installed base. We want to enable our customers to treat more indications, better and faster, which will improve the quality of life of patients, and strengthen the resilience of Proton Therapy centers."
"IBA provided the first proton therapy center to treat patients in Spain at  Quirónsalud Proton Therapy Center in Madrid, in Dec 2019: "After a successful ramp-up, we are very happy to share our experience with the Proteus®ONE* compact open-gantry solution with an organized tour of our facility", Alejandro Mazal, head of Physics at Quironsalud, added.

More information: www.iba-worldwide.com

Related Content

News | Prostate Cancer

January 19, 2022 — For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used ...

Time January 19, 2022
arrow
News | Lung Imaging

January 17, 2022 — A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung ...

Time January 17, 2022
arrow
News | Radiation Therapy

January 13, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time January 13, 2022
arrow
News | Radiation Therapy

January 10, 2022 — Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time January 10, 2022
arrow
News | Radiation Oncology

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

Time January 07, 2022
arrow
News | Radiation Oncology

January 7, 2022 — A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to ...

Time January 07, 2022
arrow
News | Proton Therapy

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
News | Radiation Oncology

December 30, 2021 — IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the ...

Time December 30, 2021
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
News | Radiation Therapy

December 22, 2021 — Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor by ...

Time December 22, 2021
arrow
Subscribe Now